Skip to Main content Skip to Navigation
Master Thesis

Les anticorps monoclonaux comme biosimilaires thérapeutiques : cibles, modes d’actions et aspects pharmaco-économiques

Abstract : The development of monoclonal antibodies (mAb) brought new hope for treating incurable diseases or, in some cases, for replacing treatments with heavy side effects. The progress of this therapeutics was made possible through a constant development of production and control techniques that are increasingly mastered. The mAb option, with a single concept of target specificity, actually gave rise to a family of biosimilar therapeutics with similar mechanisms of action (ADCC / CDC / neutralization / function block) but acting on different targets. Despite some level of control of this family and with the benefit of hindsight of about a decade, therapeutic monitoring using laboratory tests have to be set up for some mAbs, or to be developed further for others, to ensure an effective therapeutic monitoring and improve the quality of care related to the use of biopharmaceuticals. This approach will certainly make savings in terms of cost, decreased side effects, prevention of accidents related to incompatibilities. These efforts must finally improve the patient quality life while increasing the rate of therapeutic success. From an economic point of view, this family of drugs is booming and will trustingly, in view of its current growth, gain significant market shares.
Document type :
Master Thesis
Complete list of metadata

Cited literature [77 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-01165683
Contributor : Jean-Hugues Morneau <>
Submitted on : Friday, June 19, 2015 - 5:07:59 PM
Last modification on : Tuesday, May 11, 2021 - 11:36:18 AM
Long-term archiving on: : Tuesday, April 25, 2017 - 6:17:35 PM

Identifiers

  • HAL Id : dumas-01165683, version 1

Citation

Saad Charef-Eddine Nouar. Les anticorps monoclonaux comme biosimilaires thérapeutiques : cibles, modes d’actions et aspects pharmaco-économiques. Sciences pharmaceutiques. 2015. ⟨dumas-01165683⟩

Share

Metrics

Record views

266

Files downloads

6578